Skip to content

Clinical trials

Phase 2/3 Hematologic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 2/3 Country / region: Italy Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda Ospedaliera San Giovanni Battista1
Gamida Cell -Teva Joint Venture Ltd.1
Kiadis Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms3
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Graft vs Host Disease1
Hodgkin Disease1
Leukemia, Lymphoid1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid1
Leukemia, Myeloid, Acute1
Lymphoma1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.